According to filings with the U.S. Securities and Exchange Commission, Pi Health is raising up to $18 Million in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Pi Health
Pi Health is building the AI-native operating system for global drug development. Our platform, FICS, delivers breakthrough efficiencies, accelerates timelines, and ensures the highest data quality in clinical trialsempowering pharmaceutical companies and health systems to bring life-changing treatments to patients faster than ever before. With a global team and a technology-integrated site network spanning five continents, Pi Health is committed to expanding access to innovative medicines and ensuring that patients around the world can participate in cutting-edge clinical research.

To learn more about Pi Health, visit https://www.pihealth.ai/
Pi Health Linkedin Page: https://www.linkedin.com/company/pi-health-global/

Contact:
Bobby Reddy, Chief Executive Officer
908-938-1276
https://www.linkedin.com/in/bobby-reddy/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.